Heerfordt syndrome

From WikiMD's WELLNESSPEDIA


Heerfordt syndrome
Synonyms Uveoparotid fever
Pronounce N/A
Specialty N/A
Symptoms Fever, parotitis, anterior uveitis, facial nerve palsy
Complications Chronic sarcoidosis
Onset Typically in adulthood
Duration Variable
Types N/A
Causes Unknown, associated with sarcoidosis
Risks Genetic predisposition, autoimmune disease
Diagnosis Clinical evaluation, biopsy, imaging studies
Differential diagnosis Sjogren's syndrome, mumps, Bell's palsy
Prevention N/A
Treatment Corticosteroids, immunosuppressive therapy
Medication N/A
Prognosis Generally good with treatment
Frequency Rare
Deaths N/A


Heerfordt Syndrome is a rare disorder characterized by parotid gland enlargement, uveitis, facial nerve palsy, and fever. It is also known as Heerfordt-Waldenstrom syndrome and is a subtype of sarcoidosis, a condition that causes inflammation in various parts of the body.

Symptoms[edit]

The symptoms of Heerfordt Syndrome can vary greatly from person to person. The most common symptoms include:

Causes[edit]

The exact cause of Heerfordt Syndrome is unknown. However, it is believed to be a subtype of sarcoidosis, a condition that causes inflammation in various parts of the body.

Diagnosis[edit]

Diagnosis of Heerfordt Syndrome is often challenging due to its rarity and the variety of symptoms. It is typically diagnosed through a combination of clinical examination, imaging studies, and biopsy of affected tissues.

Treatment[edit]

Treatment for Heerfordt Syndrome is primarily aimed at managing the symptoms. This may include medications to reduce inflammation and control symptoms, as well as physical therapy to manage facial nerve palsy.

Prognosis[edit]

The prognosis for individuals with Heerfordt Syndrome is generally good, with most individuals experiencing a full recovery with appropriate treatment. However, the condition can be chronic and relapsing in some cases.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.